John Mascarenhas, Terrence J. Bradley, Bart L. Scott, Habte Aragaw Yimer, Souria Dougherty, Lixian Peng, Fei Huang, Ying Wan, Faye Feller, Vivian Rodolf, Judy Ho, Tymara Berry, Andrew Tucker Kuykendall, Salman Otoukesh. "IMproveMF update: Phase 1/1B trial of imetelstat (IME)+ruxolitinib (RUX) in patients (pts) with intermediate (INT)-1, INT-2, or high-risk (HR) myelofibrosis (MF).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6515